Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | 387,225 | reported | 09 Feb 2026 | tx 20+2,766,667−771,109 |
| COLLEGIUM PHARMACEUTICAL, INC | 49,365 | reported | 16 May 2024 | tx 4+49,365 |
| Travere Therapeutics, Inc. | 26,988 | reported | 16 May 2019 | tx 16+332,671−24,471 |
| Adamas Pharmaceuticals Inc | 0 | reported | 24 Nov 2021 | tx 9+1,050,000−1,050,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | SALE | ZEVRA THERAPEUTICS, INC. | 14,625 | 8.56 USD | |
| 07 Feb 2026 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 37,500 | — | |
| 07 Feb 2026 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 37,500 | 0.00 USD | deriv |
| 02 Feb 2026 | SALE | ZEVRA THERAPEUTICS, INC. | 91,000 | 9.38 USD | |
| 31 Jan 2026 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 233,334 | — | |
| 31 Jan 2026 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 233,334 | 0.00 USD | deriv |
| 29 Jan 2026 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 125,000 | 0.00 USD | deriv |
| 29 Jan 2026 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 250,000 | 0.00 USD | deriv |
| 10 Oct 2025 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 50,000 | — | |
| 10 Oct 2025 | SALE | ZEVRA THERAPEUTICS, INC. | 19,500 | 10.82 USD | |
| 10 Oct 2025 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 14 Feb 2025 | SALE | ZEVRA THERAPEUTICS, INC. | 30,544 | 8.05 USD | |
| 13 Feb 2025 | SALE | ZEVRA THERAPEUTICS, INC. | 61,273 | 7.86 USD | |
| 07 Feb 2025 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 112,500 | 0.00 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 225,000 | 0.00 USD | deriv |
| 31 Jan 2025 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 233,333 | — | |
| 31 Jan 2025 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 233,333 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 7,693 | 0.00 USD | |
| 31 Jan 2024 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 700,000 | 0.00 USD | deriv |
| 10 Oct 2023 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 600,000 | 0.00 USD | deriv |
| 10 Oct 2023 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 200,000 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 9,792 | 0.00 USD | |
| 19 May 2022 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 14,035 | 0.00 USD | |
| 06 Apr 2022 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 17,845 | 0.00 USD | |
| 24 Nov 2021 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 75,000 | 0.00 USD |